Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Weill Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
J Gen Intern Med. 2024 Apr;39(5):739-746. doi: 10.1007/s11606-023-08535-3. Epub 2023 Nov 22.
Guidelines recommend high-sensitivity cardiac troponin (hs-cTn) for diagnosis of myocardial infarction. Use of hs-cTn is increasing across the U.S., but questions remain regarding clinical and operational impact. Prior studies have had methodologic limitations and yielded conflicting results.
To evaluate the impact of transitioning from conventional cardiac troponin (cTn) to hs-cTn on test and resource utilization, operational efficiency, and patient safety.
Retrospective cohort study in two New York City hospitals during the months before and after transition from conventional cTn to hs-cTn at Hospital 1. Hospital 2 served as a control.
Consecutive emergency department (ED) patients with at least one cTn test resulted.
Multifaceted hs-cTn intervention bundle, including a 0/2-h diagnostic algorithm for non-ST-elevation myocardial infarction, an educational bundle, enhancements to the electronic medical record, and nursing interventions to facilitate timed sample collection.
Primary outcomes included serial cTn test utilization, probability of hospital admission, ED length of stay (LOS), and among discharged patients, probability of ED revisit within 72 h resulting in hospital admission. Multivariable regression models adjusted for age, sex, temporal trends, and interhospital differences.
The intervention was associated with increased use of serial cTn testing (adjusted risk difference: 48 percentage points, 95% CI: 45-50, P < 0.001) and ED LOS (adjusted geometric mean difference: 50 min, 95% CI: 50-51, P < 0.001). There was no significant association between the intervention and probability of admission (adjusted relative risk [aRR]: 0.99, 95% CI: 0.89-1.1, P = 0.81) or probability of ED revisit within 72 h resulting in admission (aRR: 1.1, 95% CI: 0.44-2.9, P = 0.81).
Implementation of a hs-cTn intervention bundle was associated with an improvement in serial cTn testing, a neutral effect on probability of hospital admission, and a modest increase in ED LOS.
指南建议使用高敏心肌肌钙蛋白(hs-cTn)进行心肌梗死的诊断。hs-cTn 在全美范围内的应用正在增加,但关于其对临床和运营的影响仍存在疑问。先前的研究存在方法学上的局限性,得出的结果也相互矛盾。
评估从常规心肌肌钙蛋白(cTn)向 hs-cTn 过渡对检验和资源利用、运营效率以及患者安全的影响。
在纽约市两家医院进行的回顾性队列研究,一家医院(医院 1)在从常规 cTn 向 hs-cTn 过渡前后的几个月内进行,另一家医院(医院 2)作为对照。
至少进行过一次 cTn 检测的连续急诊部(ED)患者。
hs-cTn 综合干预包,包括非 ST 段抬高型心肌梗死的 0/2 小时诊断算法、教育包、电子病历增强功能以及护理干预以促进定时样本采集。
主要结局包括连续 cTn 检测的使用、住院概率、ED 住院时间(LOS)以及出院患者在 72 小时内因 ED 复诊而再次入院的概率。多变量回归模型调整了年龄、性别、时间趋势和医院间差异。
干预措施与连续 cTn 检测的使用增加相关(调整风险差异:48 个百分点,95%置信区间:45-50,P<0.001)和 ED LOS 增加相关(调整后的几何均数差异:50 分钟,95%置信区间:50-51,P<0.001)。干预措施与入院概率之间无显著关联(调整后的相对风险[aRR]:0.99,95%置信区间:0.89-1.1,P=0.81)或在 72 小时内因 ED 复诊而再次入院的概率(aRR:1.1,95%置信区间:0.44-2.9,P=0.81)。
实施 hs-cTn 干预包与连续 cTn 检测的改善相关,对入院概率无显著影响,ED LOS 略有增加。